222 related articles for article (PubMed ID: 32542696)
21. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
Shi S; Kanasaki K; Koya D
Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
Katsura A; Suzuki HI; Ueno T; Mihira H; Yamazaki T; Yasuda T; Watabe T; Mano H; Yamada Y; Miyazono K
Genes Cells; 2016 Jan; 21(1):99-116. PubMed ID: 26663584
[TBL] [Abstract][Full Text] [Related]
24. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
25. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
Zhao H; Wang Y; Zhang X; Guo Y; Wang X
Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.
Srivastava SP; Goodwin JE; Kanasaki K; Koya D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085655
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
28. Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17.
Yan M; Chen K; Sun R; Lin K; Qian X; Yuan M; Wang Y; Ma J; Qing Y; Xu J; Wei M; Huang D; Li J
Exp Cell Res; 2019 Aug; 381(2):191-200. PubMed ID: 31075259
[TBL] [Abstract][Full Text] [Related]
29. Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus.
Wang D; Wang H; Liu C; Mu X; Cheng S
J Diabetes Complications; 2019 May; 33(5):374-382. PubMed ID: 30862410
[TBL] [Abstract][Full Text] [Related]
30. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
[TBL] [Abstract][Full Text] [Related]
31. Huayu Tongmai Granules protects against vascular endothelial dysfunction via up-regulating miR-185 and down-regulating RAGE.
Liu X; Wang D; Yang X; Lei L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201694
[No Abstract] [Full Text] [Related]
32. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-301a-3p promotes diabetic retinopathy via regulation of six-transmembrane epithelial antigen of prostate 4.
Wang Y; Gao L; Li Z; Ma X
Inflamm Res; 2021 Apr; 70(4):445-457. PubMed ID: 33609142
[TBL] [Abstract][Full Text] [Related]
34. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
Han N; Tian W; Yu N; Yu L
J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
[TBL] [Abstract][Full Text] [Related]
35. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy.
Guan G; Xie J; Dai Y; Han H
J Biol Chem; 2022 Mar; 298(3):101725. PubMed ID: 35157852
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
[TBL] [Abstract][Full Text] [Related]
37. MiR-21-3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor.
Shi P; Zhao XD; Shi KH; Ding XS; Tao H
Exp Cell Res; 2021 Feb; 399(2):112464. PubMed ID: 33385416
[TBL] [Abstract][Full Text] [Related]
38. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
39. MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3.
Wang C; Lin Y; Fu Y; Zhang D; Xin Y
Pflugers Arch; 2020 Nov; 472(11):1607-1618. PubMed ID: 32648125
[TBL] [Abstract][Full Text] [Related]
40. miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus.
Hulshoff MS; Schellinger IN; Xu X; Fledderus J; Rath SK; Wong FC; Maamari S; Haunschild J; Krenning G; Raaz U; Zeisberg EM
Diabetol Metab Syndr; 2023 Jan; 15(1):11. PubMed ID: 36698180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
